Default Category
-
BeiGene
Shih, Willy; Zhang, JimmyCase HBS-618033-EStrategyBeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeStarting at €8.20
-
BeiGene, PowerPoint Supplement
Shih, Willy; Zhang, JimmyCase HBS-618043-EStrategyPowerPoint slides for case 618033.Starting at €8.20
-
BeiGene, Teaching Note
Shih, Willy; Zhang, JimmyTeaching Note HBS-618039-EStrategyTeaching Note for 618033 BeiGene. BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window of opportunity to develop drug candidates toward known targets with known mechanisms of actions that would allow it to become first-in-class in Ch...Starting at €0.00
-
Wyndham Destinations Asia Pacific: Acquisition and Appraisal of Resort Frontier Co. Ltd. and Management of Sundance Resort Club Japan
Colette Southam; Mike Raybould; Joshua Poi; Matthew WinklerCase IVEY-W25639-EFinance, StrategyOn July 8, 2019, Barry Robinson, president and managing director of International Operations for Wyndham Destinations Asia Pacific (Wyndham Destinations AP), and Liam Crawley, chief financial officer, were in receipt of a report provided by law firm Baker McKenzie’s Corporate Mergers and Acquisitions team. Wyndham Destinations AP was in the process of acquiring the privately held Resort Frontier Co. Ltd., the management company for Sundance Resor...Starting at €8.20
-
Wyndham Destinations Asia Pacific: Acquisition and Appraisal of Resort Frontier Co. Ltd. and Management of Sundance Resort Club Japan- Teaching Note
Colette Southam; Mike Raybould; Joshua Poi; Matthew WinklerTeaching Note IVEY-W25640-EFinance, StrategyTeaching note for product W25639.Starting at €0.00